Evidence map›Paper›PMID 23025283›Full record

ArticleBiochemistry2012

Complete thermodynamic and kinetic characterization of the isomer-specific interaction between Pin1-WW domain and the amyloid precursor protein cytoplasmic tail phosphorylated at Thr668.

Soumya De, Alexander I Greenwood, Monique J Rogals, Evgenii L Kovrigin, Kun Ping Lu, Linda K Nicholson

Abstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Backbone double-mutant cycle analysis quantifies hydrogen-bond energies in proteins.Protein science : a publication of the Protein Society · 2026
    Article
  2. Ligand-induced protein transition state stabilization switches the binding pathway from conformational selection to induced fit.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Networks of Dynamic Allostery Regulate Enzyme Function.Structure (London, England : 1993) · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).The Journal of biological chemistry · 2015
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Soumya DeDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.
Alexander I Greenwood
Monique J Rogals
Evgenii L Kovrigin
Kun Ping Lu
Linda K Nicholson
Cornell University · USBeth Israel Deaconess Medical Center · USMarquette University · US

Funding

Role of the Prolyl Isomerase Pin1 in the Development and Treatment of AsthmaR01HL111430 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LU, KUN PING · 2012 to 2015
$2.7M
Conformational Dynamics in Pin1 REgulation of APP Processing and Abeta ProductionR01AG029385 · NIA · CORNELL UNIVERSITY · PI NICHOLSON, LINDA K · 2007 to 2011
$2.3M
Pin1-Catalyzed Protein Conformational Regulation in Alzheimer's DiseaseR01AG039405 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LU, KUN PING · 2011 to 2015
$1.8M
NHLBI NIH HHS R01 HL111430NIA NIH HHS R01 AG029385NIA NIH HHS R01-AG029385NIA NIH HHS R01 AG039405
6 · The paper itself

Abstract

Peptidyl prolyl cis-trans isomerization acts as an effective molecular timer that plays significant roles in biological and pathological processes. Enzymes such as Pin1 catalyze cis-trans isomerization, accelerating the otherwise slow isomerization rate into time scales relevant for cellular signaling. Here we have combined NMR line shape analysis, fluorescence spectroscopy, and isothermal titration calorimetry to determine the kinetic and thermodynamic parameters describing the trans-specific interaction between the binding domain of Pin1 (WW domain) and a key cis-trans molecular switch in the amyloid precursor protein cytoplasmic tail. A three-state model, in which the cis-trans isomerization equilibrium is coupled to the binding equilibrium through the trans isomer, was found to fit the data well. The trans isomer binds the WW domain with ∼22 μM affinity via very fast association (approaching the diffusion limit) and dissociation rates. The common structural and electrostatic characteristics of Pin1 substrates, which contain a phosphorylated serine/threonine-proline motif, suggest that very rapid binding kinetics are a general feature of Pin1 interactions with other substrates. The fast binding kinetics of the WW domain allows rapid response of Pin1 to the dynamic events of phosphorylation and dephosphorylation in the cell that alter the relative populations of diverse Pin1 substrates. Furthermore, our results also highlight the vastly different rates at which slow uncatalyzed cis-trans isomerization and fast isomer-specific binding events occur. These results, along with the experimental methods presented herein, should guide future experiments aimed at the thermodynamic and kinetic characterization of cis-trans molecular switches and isomer-specific interactions involved in various biological processes.

Indexed as

Amyloid beta-Protein PrecursorBinding SitesHumansIsomerismKineticsModels, MolecularNIMA-Interacting Peptidylprolyl IsomeraseNuclear Magnetic Resonance, BiomolecularPeptidylprolyl IsomerasePhosphorylationProtein BindingProtein Interaction MappingProtein Structure, TertiaryThermodynamicsTryptophanAmyloid beta-Protein PrecursorNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePIN1 protein, humanTryptophan

Identifiers

PMID23025283
PMCPMC3548994
OpenAlexW2050578817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.